Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg - Net Worth and Insider Trading

Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg owns 6 companies in total, including Syndax Pharmaceuticals Inc (SNDX) , Chiasma Inc (CHMA) , and TriVascular Technologies Inc (TRIV) among others .

Click here to see the complete history of Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg’s form 4 insider trades.

Insider Ownership Summary of Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg

Ticker Comapny Transaction Date Type of Owner
SNDX Syndax Pharmaceuticals Inc 2016-03-02 10 percent owner
CHMA Chiasma Inc 2015-07-21 10 percent owner
TRIV TriVascular Technologies Inc 2014-04-22 10 percent owner
LIMIT LIMIT 2013-05-30 10 percent owner
LIMIT LIMIT 2013-07-24 10 percent owner
LIMIT LIMIT 2011-02-02 10 percent owner

Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg Ownership Network

Ownership Network List of Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg

No Data

Ownership Network Relation of Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg

Insider Network Chart

Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg Owned Company Details

What does Syndax Pharmaceuticals Inc do?

Who are the key executives at Syndax Pharmaceuticals Inc?

Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg is the 10 percent owner of Syndax Pharmaceuticals Inc. Other key executives at Syndax Pharmaceuticals Inc include Chief Financial Officer Keith A. Goldan , director & Chief Executive Officer Briggs Morrison , and President & Head of R&D Neil Gallagher .

Syndax Pharmaceuticals Inc (SNDX) Insider Trades Summary

Over the past 18 months, Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 264,275 shares made by Briggs Morrison , a net purchase of 673 shares made by Keith A. Goldan , and a net sale of 83,000 shares made by William Meury .

In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 347,852 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 1,250 shares were bought by its insiders, resulting in a net sale of 346,602 shares.

Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Syndax Pharmaceuticals Inc Insider Transactions

No Available Data

Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg Mailing Address

Above is the net worth, insider trading, and ownership report for Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg. You might contact Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg via mailing address: The John Hancock Tower, 200 Clarendon Street, 54th Floor, Boston Ma 02116.

Discussions on Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg

No discussions yet.